[68Ga]Ga-DOTA-ST8950

N/A

Report date: 2025/11/20 16:03:56

NME

Base Information

Drug Name[68Ga]Ga-DOTA-ST8950

Drug Alias Name[68Ga]Ga-DOTA-ST895068Ga-DOTA-ST8950

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor 2 bindersSomatostatin receptor 5 binders

TargetsSomatostatin receptor 2Somatostatin receptor 5

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Hospital Basel

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Basel

Inactive CompaniesN/A

Active IndicationsNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A